{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:03:15Z","timestamp":1780567395629,"version":"3.54.1"},"reference-count":38,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"publisher","award":["DS 410"],"award-info":[{"award-number":["DS 410"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"publisher","award":["DS640"],"award-info":[{"award-number":["DS640"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Pediatric inflammatory, multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS), also known as a multisystem inflammatory syndrome in children (MIS-C), is diagnosed in children who develop an inadequate inflammatory response after exposure to the SARS-CoV-2 virus. The pathogenesis of the abnormal response of the immune system to a previous SARS-COV-2 infection has not been explained. Similarly, the safety and effectiveness of COVID-19 vaccinations in this group of patients have become the subject of clinical discussion. Presenting experiences from many centers aims to answer this question. We present 4 cases of patients who suffered from PIMS-TS. Three of them were safely vaccinated against COVID-19 after illness. One patient developed PIMS-TS temporarily associated with COVID-19 vaccination. We also collected and discussed data from other centers.<\/jats:p>","DOI":"10.3390\/vaccines12030278","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T08:59:37Z","timestamp":1709801977000},"page":"278","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-SARS-CoV-2 Vaccination and PIMS-TS\u2014Friends or Foe? Case Reports and Literature Review"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1644-5568","authenticated-orcid":false,"given":"Violetta","family":"Opoka-Winiarska","sequence":"first","affiliation":[{"name":"Department of Pediatric Pulmonology and Rheumatology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Morawska-Michalska","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-6659","authenticated-orcid":false,"given":"Paulina","family":"Mertowska","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Gosik","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"K\u0105dzio\u0142ka","sequence":"additional","affiliation":[{"name":"Department of Paediatric Pulmonology and Rheumatology, University Children\u2019s Hospital of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-4741","authenticated-orcid":false,"given":"Ewelina","family":"Grywalska","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Opoka-Winiarska, V., Grywalska, E., and Roli\u0144ski, J. (2021). PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection\u2014\u201cRheumatic Fever\u201d of the 21st Century?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094488"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaci.2020.07.033","article-title":"Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1","volume":"146","author":"Lee","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"874687","DOI":"10.3389\/fpubh.2022.874687","article-title":"COVID-19 Vaccination in Pediatric Population: A Necessity or Obstruction to the Protection of the Right to Health? Biojuridical Perspective","volume":"10","author":"Bilotta","year":"2022","journal-title":"Front. Public Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.15585\/mmwr.mm6932e2","article-title":"COVID-19\u2013Associated Multisystem Inflammatory Syndrome in Children\u2014United States, March\u2013July 2020","volume":"69","author":"Bryant","year":"2020","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem Inflammatory Syndrome in U.S. Children and Adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"eabn9237","DOI":"10.1126\/scitranslmed.abn9237","article-title":"SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children","volume":"14","author":"Bartsch","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e068898","DOI":"10.1136\/bmj-2021-068898","article-title":"Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: Cohort study","volume":"377","author":"Kildegaard","year":"2022","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa2203315","article-title":"Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age","volume":"386","author":"Creech","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_10","unstructured":"(2024, February 02). CSTE\/CDC Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection Surveillance Case Report Form Guidance, Effective January 1, 2023, Available online: https:\/\/www.cdc.gov\/mis\/pdfs\/MIS-C_case-report-form-guidance-document.pdf."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/INF.0000000000003713","article-title":"Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study","volume":"41","author":"Buonsenso","year":"2022","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapediatrics.2022.2206","article-title":"Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron Wave","volume":"176","author":"Holm","year":"2022","journal-title":"JAMA Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15585\/mmwr.mm7102e1","article-title":"Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12\u201318 Years\u2014United States, July\u2013December 2021","volume":"71","author":"Zambrano","year":"2022","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.2021.23262","article-title":"Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France","volume":"327","author":"Levy","year":"2022","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1097\/INF.0000000000003249","article-title":"Second Episode of Multisystem Inflammatory Syndrome in Children: Relapse, Rebound, or Recurrence?","volume":"40","author":"Pawar","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1097\/INF.0000000000003280","article-title":"Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Without Recurrence of Multisystem Inflammatory Syndrome in Children","volume":"40","author":"Buddingh","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1030083","DOI":"10.3389\/fped.2022.1030083","article-title":"Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey","volume":"10","author":"Minoia","year":"2022","journal-title":"Front. Pediatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e224750","DOI":"10.1001\/jamanetworkopen.2022.4750","article-title":"Outcomes After SARS-CoV-2 Vaccination Among Children With a History of Multisystem Inflammatory Syndrome","volume":"5","author":"Wisniewski","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s12519-022-00604-7","article-title":"Frequency and safety of COVID-19 vaccination in children with multisystem inflammatory syndrome: A telephonic interview-based analysis","volume":"18","author":"Aykac","year":"2022","journal-title":"World J. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpeds.2022.05.028","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey","volume":"248","author":"Hoste","year":"2022","journal-title":"J. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/jpids\/piac076","article-title":"Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain","volume":"11","author":"Epalza","year":"2022","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3201\/eid2805.212418","article-title":"Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination","volume":"28","author":"Jain","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.arcped.2022.08.018","article-title":"Two pediatric cases of multisystem inflammatory-like syndrome following COVID-19 vaccination","volume":"29","author":"Collignon","year":"2022","journal-title":"Arch. P\u00e9diatrie"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"896903","DOI":"10.3389\/fped.2022.896903","article-title":"Case Report: MIS-C With Prominent Hepatic and Pancreatic Involvement in a Vaccinated Adolescent\u2014A Critical Reasoning","volume":"10","author":"Consolini","year":"2022","journal-title":"Front. Pediatr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3201\/eid2707.210594","article-title":"Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination","volume":"27","author":"Salzman","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1097\/INF.0000000000003444","article-title":"Multisystem Inflammatory Syndrome in a Previously Vaccinated Adolescent Female With Sickle Cell Disease","volume":"41","author":"DeJong","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1097\/INF.0000000000003451","article-title":"Multisystem Inflammatory Syndrome in Children After Breakthrough Infection in a COVID-19\u2013vaccinated Child","volume":"41","author":"Lee","year":"2022","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Santilli, V., Manno, E.C., Giancotta, C., Rossetti, C., Cotugno, N., Amodio, D., Rotulo, G.A., Deodati, A., Bianchi, R., and Lucignani, G. (2022). Two Pediatric Cases of Multisystem Inflammatory Syndrome with Overlapping Neurological Involvement Following SARS-CoV-2 Vaccination and Unknown SARS-CoV2 Infection: The Importance of Pre-Vaccination History. Vaccines, 10.","DOI":"10.3390\/vaccines10071136"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100393","DOI":"10.1016\/j.lanepe.2022.100393","article-title":"Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study","volume":"17","author":"Ouldali","year":"2022","journal-title":"Lancet Reg. Heal.-Eur."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/INF.0000000000003432","article-title":"A Case of Multisystem Inflammatory Syndrome in a 12-Year-old Male After COVID-19 mRNA Vaccine","volume":"41","author":"Polat","year":"2022","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e247176","DOI":"10.1136\/bcr-2021-247176","article-title":"Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination","volume":"15","author":"Wangu","year":"2022","journal-title":"BMJ Case Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S2352-4642(22)00028-1","article-title":"Reported cases of multisystem inflammatory syndrome in children aged 12\u201320 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: A surveillance investigation","volume":"6","author":"Yousaf","year":"2022","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e01606","DOI":"10.1016\/j.idcr.2022.e01606","article-title":"Multisystem inflammatory syndrome in children (MIS-C) secondary to COVID-19 mRNA vaccination\u2014A case report from Qatar","volume":"30","author":"Varghese","year":"2022","journal-title":"IDCases"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2107456","article-title":"Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents","volume":"385","author":"Frenck","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa2109522","article-title":"Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents","volume":"385","author":"Ali","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2116298","article-title":"Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age","volume":"386","author":"Walter","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/infdis\/jiac215","article-title":"Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants in Children With Coronavirus Disease 2019, Multisystem Inflammatory Syndrome in Children, and After Two Doses of BNT162b2 Vaccination","volume":"226","author":"Rostad","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_38","unstructured":"(2022, December 07). Clinical Guidance for COVID-19 Vaccination|CDC, Available online: https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/interim-considerations-us.html."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/3\/278\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:10:20Z","timestamp":1760105420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/3\/278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["vaccines12030278"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12030278","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]}}}